EUVIMEDEUVIMED entdecken
Open Access

Melanoma-derived versican reactivates tumor-associated macrophages by upregulating pyruvate carboxylase through TLR2-MyD88-RelB axis under normoxia

Yuxin Shu, Linmin Zhou, Jinqin Qian, Wei-Guo Zhu

Acta Biochimica et Biophysica Sinica · 2025

DOI: 10.3724/abbs.2025011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2025. Verfasst von Yuxin Shu und 3 weiteren Autor:innen. Beteiligte Einrichtung: International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Department of Biochemistry and Molecular Bi…. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Myeloid Differentiation Factor 88, Tumor-Associated Macrophages, Versicans. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Relieving hypoxia in the tumor microenvironment (TME) promotes innate and adaptive immunity. Our previous research demonstrated that reoxygenation of the TME promotes the phagocytosis and tumor-killing functions of tumor-associated macrophages (TAMs) by upregulating pyruvate carboxylase (PCB). However, the mechanism remains obscure. In the present study, we find that versican derived from melanoma cells binds to TLR2 and activates the downstream transcription factor RelB, which transcribes PCB under normoxia. Blocking the versican-TLR2-MyD88-RelB axis not only reverses the upregulation of PCB in TAMs but also hinders the clearance of tumor cells by TAMs. Our work suggests a pathway that modulates the functions of TAMs under normoxia, which could be harnessed for strengthening anti-tumor immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 2Myeloid Differentiation Factor 88Tumor-Associated MacrophagesVersicansMelanomaAnimalsUp-RegulationMiceTumor MicroenvironmentSignal TransductionCell Line, TumorHumans

Stichwörter der Autor:innen

RelBphagocytosispyruvate carboxylasetumor-associated macrophagesversican

Substanzen

Toll-Like Receptor 2Myeloid Differentiation Factor 88VersicansTlr2 protein, mouse

Autor:innen und Institutionen

  • International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen 518060, China.
  • School of Basic Medical Sciences, Wannan Medical College, Wuhu 241002, China.
  • School of Pharmaceutical Sciences, Shenzhen University Health Science Center, Shenzhen 518055, China.
  • Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center of China, Beijing 100034, China.

Zitieren

APA

Shu, Y., Zhou, L., Qian, J., & Zhu, W. G. (2025). Melanoma-derived versican reactivates tumor-associated macrophages by upregulating pyruvate carboxylase through TLR2-MyD88-RelB axis under normoxia. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025011

Vancouver

Shu Y, Zhou L, Qian J, Zhu WG. Melanoma-derived versican reactivates tumor-associated macrophages by upregulating pyruvate carboxylase through TLR2-MyD88-RelB axis under normoxia. Acta Biochimica et Biophysica Sinica. 2025. doi:10.3724/abbs.2025011

BibTeX
@article{Shu2025,
  author = {Shu, Yuxin and Zhou, Linmin and Qian, Jinqin and Zhu, Wei-Guo},
  title = {Melanoma-derived versican reactivates tumor-associated macrophages by upregulating pyruvate carboxylase through TLR2-MyD88-RelB axis under normoxia},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2025},
  doi = {10.3724/abbs.2025011}
}
Kostenlos starten →